Relevant bibliographies by topics / Oral iron

Academic literature on the topic 'Oral iron'

Author: Grafiati
Published: 10 December 2022
Last updated: 28 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Oral iron.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Oral iron"

1

Cappellini, Maria Domenica, and Paolo Pattoneri. "Oral Iron Chelators." Annual Review of Medicine 60, no. 1 (February 2009): 25–38. http://dx.doi.org/10.1146/annurev.med.60.041807.123243.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hansen, Christine M. "Oral Iron Supplements." American Pharmacy 34, no. 3 (March 1994): 66–71. http://dx.doi.org/10.1016/s0160-3450(15)30485-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kwiatkowski, Janet L. "Oral Iron Chelators." Pediatric Clinics of North America 55, no. 2 (April 2008): 461–82. http://dx.doi.org/10.1016/j.pcl.2008.01.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kwiatkowski, Janet L. "Oral Iron Chelators." Hematology/Oncology Clinics of North America 24, no. 1 (February 2010): 229–48. http://dx.doi.org/10.1016/j.hoc.2009.11.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Dunea, G., M. A. Swagel, U. Bodiwala, and J. A. L. Arruda. "Intradialytic Oral Iron Therapy." International Journal of Artificial Organs 17, no. 5 (May 1994): 261–64. http://dx.doi.org/10.1177/039139889401700503.

Full text
Abstract:
In order to test the limits of what can be achieved with oral iron therapy and eliminate the factor of noncompliance, we conducted a series of observational studies in an 140-patient inner city dialysis unit. In these studies the patients received supervised iron therapy as 3-4 ferrous sulfate (325 mg) tablets during each dialysis. Acceptance and tolerance was high, less than 10% refusing to take the tablets. In two separate observational studies oral intradialytic iron yielded a hematocrit 28% in 69% of patients and 30% in 42-52%. There was no correlation between the final hematocrit and serum ferritin or transferrin saturation. The response to iron therapy could frequently not be predicted by the ferritin levels or transferrin saturation. We conclude that in view of the known hazards of intravenous iron dextran, oral intradialityc therapy should be tried first and that a good response can be expected in one half to two thirds of hemodialysis patients.
APA, Harvard, Vancouver, ISO, and other styles
6

Forman, Edwin. "Goodbye oral iron therapy?" Pediatric Blood & Cancer 60, no. 11 (July 30, 2013): 1731. http://dx.doi.org/10.1002/pbc.24710.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Littlewood, Tim J. "Intravenous or oral iron?" American Journal of Hematology 87, no. 2 (December 3, 2011): 134–35. http://dx.doi.org/10.1002/ajh.22249.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Arzoo, Shabera, Shereen Yousof, Jahanara Rahman, and Sameena Chowdhury. "Iron Deficiency Anemia in Pregnancy: Intravenous Iron Sucrose versus Oral Iron Sulfate." Bangladesh Journal of Obstetrics & Gynaecology 33, no. 1 (July 3, 2020): 40–44. http://dx.doi.org/10.3329/bjog.v33i1.43541.

Full text
Abstract:
Introduction: Injectable iron sucrose and oral ferrous sulfate both are used for the correctionof anaemia in second and third trimester of pregnancy. But injectable iron is supposed to bemore effective than oral iron, as it needs less time for correction of anaemia and efficacy ismore. Oral iron is cost effective but more time consuming.The objective of the study was to compare the safety of intravenous iron sucrose complex inthe treatment of iron deficiency anemia in third trimester of pregnancy. To compare theefficacy of intravenous iron with oral iron. Method: A randomised controlled trial was conducted in which pregnant women with irondeficiency were sequentially selected from the pregnant women attended antenatal clinic ofOPD of Institute of Child and Maternal Health (ICMH) and assigned either to injectable or tooral ferrous sulfate by random number table. Each study patient was given the total calculatedamount of injectable iron sucrose {Hb deficit (gm/l) × body weight (kg) × 0.24+ storage ironmg } in divided dose 200 mg in 200 ml normal saline intravenously over 1 hour everyalternate day . Each patient of the control group was given ferrous sulfate 200mg orally threetimes a day for 4 weeks. Pregnant women follow up at 4 weeks and 8 weeks after gettreatment by oral and injectable iron. During follow up monitored for adverse effects, clinicaland laboratory response and haemoglobin percentage were observed. Result: There were 75 patients in injectable group and 75 patients in oral group. Injectablegroup achieved a significantly higher Hb level (11.49 ± 0.39) than oral group Hb level (10.39± 0.75) after 8 weeks of treatment. Injectable group showed no major side effects, only twopatient had complains .One patient complain of epigastic pain and one patient complain oftachycardia while in oral group complain of nausea and vomiting, epigastic pain, constipation,allergic reaction was found in 42.0%, 39.3%,35.7% and 3.6% respectively. Conclusion: Iron sucrose complex appears to be a safe and effective in the treatment ofiron deficiency anemia. Bangladesh J Obstet Gynaecol, 2018; Vol. 33(1) : 40-44
APA, Harvard, Vancouver, ISO, and other styles
9

Garg, Apurva, Manju Agarwal, Uma Shankar, and Shrikant Shetty. "Comparative study of oral iron and intravenous iron sucrose for the treatment of iron deficiency anemia in pregnancy." International Journal of Reproduction, Contraception, Obstetrics and Gynecology 6, no. 1 (December 20, 2016): 172. http://dx.doi.org/10.18203/2320-1770.ijrcog20164652.

Full text
Abstract:
Background: The aim of this study was to compare the efficacy and safety of iron sucrose with oral iron in the treatment of iron deficiency anemia of pregnancy.Methods: An interventional comparative study was conducted at Jhalawar Medical College, Jhalawar involving 80 pregnant women with iron deficiency anemia from March 2016 to August 2016. Inclusion criteria were gestational age between 24-32 weeks with established iron deficiency anemia, with hemoglobin between 7-10g/dl. Target Hemoglobin was 11 g/dl. In intravenous iron sucrose group iron sucrose dose was calculated from following formula: total iron dose required (mg) = 2.4 x body weight in Kg x (target Hb – Patient’s Hb g/dl) + 500. In oral iron, group patient received ferrous-sulphate 335 mg daily BD. Hb level were reviewed at 2, 4, 6 weeks.Results: Change in Hemoglobin level from baseline significantly higher in IV iron group than oral iron group. In IV iron, group mean value of baseline Hb was 8.07±0.610 g/dl and in oral iron group was 8.48±0.741 g/dl. At the end of 6-week mean hemoglobin in IV iron sucrose was 10.66±0.743 g/dl and in oral iron group was 10.08±0.860 g/dl.Conclusions: Intravenous iron sucrose elevates more Hb than oral iron, with less adverse effects.
APA, Harvard, Vancouver, ISO, and other styles
10

DeLoughery, Thomas G. "Safety of Oral and Intravenous Iron." Acta Haematologica 142, no. 1 (2019): 8–12. http://dx.doi.org/10.1159/000496966.

Full text
Abstract:
As the adverse effects of iron deficiency are better recognized, the use of oral and intravenous iron has increased dramatically. Oral iron is often poorly tolerated, with up to 70% or more of patients noting gastrointestinal issues; this may affect adherence to therapy. In addition, many patients will not respond to oral iron due to their underlying illness. Intravenous iron is being used more frequently to replete iron stores. True anaphylaxis is very rare, but complement-mediated infusion reactions may be seen in up to 1 in every 200 patients. Previous concerns about intravenous iron increasing the risk of infection or cardiovascular disease are unfounded.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Oral iron"

1

Al-Refaie, Faris Nouraldin. "Oral iron chelation therapy with deferiprone (L(207))." Thesis, University College London (University of London), 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.286321.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Daba, Alina. "Insights on systemic and cellular iron homeostasis: hepcidin responses to oral and parenteral iron loading and an alternative mechanism for ferritin mRNA translation." Thesis, McGill University, 2012. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=107735.

Full text
Abstract:
Iron is vital for all living organisms, but due to its ability to readily accept or donate electrons, it is also potentially toxic. Finely tuned mechanisms have evolved to control iron homeostasis at the systemic and cellular level. The peptide hormone hepcidin controls systemic iron homeostasis by binding to and degrading the iron exporter, ferroportin, leading to decreased iron efflux from duodenal enterocytes, macrophages and hepatocytes into the blood stream. Cellular iron homeostasis is regulated by the IRE / IRP system, which controls the levels of proteins involved in iron uptake, utilization, export and storage in a coordinated manner. Excess intracellular iron is stored and detoxified in ferritin. In this work, we study how an excess of iron is managed at the systemic and cellular level. In chapter II, we hypothesize that dietary and parenteral iron loading have differential effects on body iron status and hepcidin expression in mice. We perform time – course experiments and compare the effects of dietary and parenteral iron loading on circulating and tissue iron parameters. We show that dietary iron overload exceeds the capacity of hepcidin to lower body iron levels, and parenteral iron loading elicits a delayed hepcidin response. We provide evidence that circulating holo – transferrin and hepatocytic iron are the sole iron signals for hepcidin activation. In chapter III, we examine how an excess of iron is managed at the cellular level. We hypothesize that ferritin might benefit from an alternative, IRES - dependent mechanism of translation. We inhibit global or ferritin - specific cap – dependent translation initiation and challenge the cells with iron. We show that ferritin by – passes both the global and the specific inhibition of translation. We then test for the presence of an IRES in the 5'UTR of ferritin mRNA and further validate this sequence.
Le fer est vital pour tous les organismes vivants, cependant étant donné son habilité à donner ou accepter des électrons facilement, il a aussi le potentiel d'être toxique. Des mécanismes très précis ont évolué pour contrôler l'homéostasie du fer aux niveaux systémique et cellulaire. L'hormone peptidique, hepcidine, contrôle l'homéostasie du fer au niveau systémique par la dégradation de la ferroportine, l'exportateur cellulaire du fer. En conséquence, l'efflux du fer des entérocytes, des macrophages et des hépatocytes vers la circulation diminue. Au niveau cellulaire, le système IRE / IRP contrôle, d'une manière coordonnée, les niveaux des protéines impliquées dans l'acquisition, l'utilisation, l'exportation et le stockage du fer. L'excès de fer est stocké dans la ferritine. Dans ce travail, nous examinons comment l'excès de fer est géré aux niveaux systémique et cellulaire. Dans le chapitre II, nous émettons l'hypothèse que les surcharges orale et parentérale en fer ont des effets différents sur l'homéostasie systémique du fer et sur l'expression de l'hepcidine chez les souris. Nous comparons les effets des surcharges orale et parentérale en fer aux niveaux circulatoire et tissulaire. Nous démontrons que la surcharge orale en fer excède la capacité hypoferrémique de l'hepcidine alors que la surcharge parentérale en fer induit une réponse retardée de l'hepcidine. Nous apportons aussi la preuve que la holo – transferrine circulatoire et le fer hépatocytaire sont les signaux uniques de l'activation ferrique de l'hepcidine. Dans le chapitre III, nous examinons comment l'excès de fer est géré au niveau cellulaire. Nous émettons l'hypothèse que la ferritine bénéficie d'un mécanisme alternatif de traduction, dépendant d'une séquence IRES. Nous inhibons l'initiation de la traduction dépendante de la coiffe 5' globalement, ou spécifiquement pour la ferritine, et traitons les cellules avec une source de fer. Nous démontrons que la ferritine surpasse le blocage global ou spécifique de la traduction dépendante de la coiffe 5'. Nous testons la présence d'une séquence IRES dans l'extrémité 5' de l'ARNm et par la suite nous la validons.
APA, Harvard, Vancouver, ISO, and other styles
3

Whiteside, Douglas P. "Evaluation of the oral iron chelator deferiprone in the white leghorn chicken and domestic pigeon." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2001. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp05/NQ61990.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hileti, Dona. "Biological and pharmacokinetic studies on the oral iron chelator 1, 2 dimethyl-3-hydroxpyrid-4-one." Thesis, University College London (University of London), 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.307678.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Liebe-Harkort, Carola. "Oral disease and health patterns : dental and cranial paleopathology of the early Iron Age population at Smörkullen in Alvastra, Sweden /." Stockholm : Department of Archaeology and Classical Studies, Stockholm University, 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-37301.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Escorcio, Carla Solange de Melo. "AvaliaÃÃo do tratamento da anemia em pacientes com insuficiÃncia renal crÃnica em hemodiÃlise em uso de eritropoetina, ferro oral e endovenoso." Universidade Federal do CearÃ, 2005. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=322.

Full text
Abstract:
FundaÃÃo de Amparo à Pesquisa do Estado do CearÃ
O objetivo deste estudo foi avaliar comparativamente a evoluÃÃo do tratamento da anemia em pacientes com insuficiÃncia renal crÃnica (IRC), em hemodiÃlise, em uso de eritropoetina recombinante humana (EPO), tratados com ferro oral e ferro endovenoso em Fortaleza, CearÃ, no perÃodo de janeiro de 2004 a janeiro de 2005. Trata-se de um estudo transversal observacional descrito em duas clÃnicas de hemodiÃlise em Fortaleza, CearÃ. Os dados foram coletados a partir dos prontuÃrios e mapas de exame realizados mensalmente pelos pacientes. De 165 casos selecionados, apenas 89 (54%) compuseram o banco de dados da pesquisa. Deste total 65 (71%) pacientes estavam usando exclusivamente sulfato ferroso oral, 09 (10%) faziam uso exclusivo do sacarato de hidrÃxido de ferro III administrado por via endovenosa, e 18 (19%) faziam uso de ambos. Os parÃmetros analisados durante o estudo foram: idade, sexo, tempo de diÃlise, doenÃa de base, dosagem da hemoglobina, determinaÃÃo do hematÃcrito, dosagem sÃricas do ferro sÃrico, ferritina sÃrica, Ãndice de saturaÃÃo da transferrina, capacidade latente e total de ligaÃÃo do ferro. Analisando os parÃmetros hematolÃgicos conclui-se que a anemia encontra-se bem controlada e estabilizada. PorÃm, a maioria dos pacientes apresentou ferritina sÃrica <400ng/ml e Ãndice de saturaÃÃo da transferrina (IST) <20%. Constatou-se, que houve melhora da anemia nos pacientes com IRC em hemodiÃlse, tratados com EPO e ferro oral. Todavia, para otimizar o tratamento da anemia na IRC deve-se levar em consideraÃÃo as complicaÃÃes da doenÃa de base, o grau da anemia, os estoques de ferro e os efeitos adversos relacionados a ferroterapia.
The object of this study was to compare the effectiveness of polynuclear iron (III) hydroxide sucrose complex, administered intervenously, with iron sulfate in the treatment of anemia in 89 patients with chronic renal insufficiency in hemodialysis, with r-HuEPO, in Fortaleza from January 2004 to January 2005. It was a transversal prospective study conducted in two hemodialysis clinics in Fortaleza â Cearà .the data were collected from the patients medical charts and expressed as arithmetic mean + - SD. In accordance with treatment, the patients were grouped in terms of treatment :oral and intervenous iron, and intervenous iron. The following parameters were analyzed during the study: age, gender, length of dialysis , baseline, hemogloibin, hematocrit , serum iron , serum ferritin, saturation level of transferrina, latent capacity and bonding of iron. It was establish that there occurred no superior effectiveness with polynuclear iron (III) hydroxide sucrose complex, administered intervaneously, in the treatment of anemia in patients with IRC in hemodialysis, in the use of r-HuEPO. The analyzed parameters during the study verified indirectly the supply of iron. Consequently, it was not possible to establish a confident and precise determination of the deficiency or oversupply of iron in these patients.
APA, Harvard, Vancouver, ISO, and other styles
7

Back, Danielsson Ing-Marie. "Masking Moments : The Transitions of Bodies and Beings in Late Iron Age Scandinavia." Doctoral thesis, Stockholm : Department of Archaeology and Classical Studies, 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-6737.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Andersson, Josefina. "Bildstenarna och den muntliga traditionen på Gotland under yngre järnålder." Thesis, University of Kalmar, School of Human Sciences, 2009. http://urn.kb.se/resolve?urn=urn:nbn:se:hik:diva-2122.

Full text
Abstract:

Andersson, J. 2008. Bildstenarna och den muntliga traditionen på Gotland under yngre järnålder. The Picture Stones and the Oral Tradition of Gotland During the Late Iron Age. Högskolan i Kalmar ht 2008.

This is a study of the picture stones of Gotland and the oral tradition connected to them. This study consists of two main parts; in the main part the discussion focus on the oral tradition and the continuity of the same, where the memory plays a significant role. It also contains a discussion of the physical environment and its influences of the oral tradition. The second part concentrates around the picture stones, the variation of the scenes and the numerous of them. 

Keywords: oral traditions, picture stones, late iron age, Gotland, Nordic mythology.

 

 

APA, Harvard, Vancouver, ISO, and other styles
9

Omur-Ozbek, Pinar. "Macromolecular Reactions and Sensory Perception at the Air-Water-Human Interface." Diss., Virginia Tech, 2008. http://hdl.handle.net/10919/77226.

Full text
Abstract:
During 20th century main concern was to have sanitary water flowing through the tap. In 21st century constant supply of safe drinking water is common at any home in USA. Hence consumers pay attention to aesthetic quality of tap water. Odorous algal metabolites in source water and metals introduced to drinking water due to corrosion of pipes in the distribution system cause taste, odor and color problems, and result in complaints and perception of tap water as unhealthy. Millions of dollars are spent each year by water industry to address and prevent these issues. This research focused on some of the taste-and-odor issues associated with drinking water. First aim was to understand when geosmin, 2-MIB, and nonadienal become detectable, employing two-resistance mass transfer theory to determine the concentration of odorants in bathroom air. Results showed that water temperature and odorant concentration in water play an important role. Next focus was to develop an international odor standard to be used for training of sensory analysis panelists. There are many sensory methods to monitor drinking water to detect the off-flavors however an odor standard has been missing. Hexanal was studied with trained flavor profile analysis panels and was proposed as an ideal odor reference standard to be used for training and sensory assessment of water samples. Main focus was to understand metallic flavor of drinking water caused by iron and copper. It was shown that metallic sensation has taste and retronasal components creating the flavor and humans are very sensitive to it. Occurrence of lipid oxidation in the oral cavity was shown when metals were ingested, that produces carbonyls which are responsible for the metallic flavor. Antioxidants and chelators were investigated to study prevention of lipid oxidation and, chelators were determined to be more effective. Oral epithelial cell cultures were developed as a model for oral cavity to further investigate lipid oxidation and effectiveness of the antioxidants and chelators. This dissertation is a result of inter-disciplinary work and possibly a good example for how problems may be solved by incorporating different methods and point of views from several disciplines.
Ph. D.
APA, Harvard, Vancouver, ISO, and other styles
10

Méndez, Francia Paola Alexandra, and Capcha Talia Lizbethy Misayauri. "Análisis de estudio de cohorte: factores asociados a la adherencia mensual a la suplementación oral de hierro en gestantes de Ayacucho y Andahuaylas entre 2006 y 2007." Bachelor's thesis, Universidad Peruana de Ciencias Aplicadas (UPC), 2021. http://hdl.handle.net/10757/655227.

Full text
Abstract:
La anemia en gestantes es un problema de salud pública importante a nivel mundial. Según la prevalencia registrada, en Perú persiste como un problema moderado. La pobre adherencia a la suplementación oral de hierro es una de las principales barreras para la efectividad de esta intervención. El objetivo del presente estudio fue determinar la variación de la adherencia a la suplementación oral de hierro en el tiempo y los factores asociados a esta. Para ello, se reanalizó la base de datos de la vigilancia centinela: “Estudio de adherencia a la suplementación con Hierro durante la gestación en las direcciones de salud de Apurímac y Ayacucho” de la Dirección General de Epidemiología (DGE), el cual tuvo un diseño de cohorte prospectiva longitudinal. Se realizó un análisis descriptivo de las 416 gestantes registradas y un análisis bivariado y multivariado en base a 376 gestantes. Se identificaron las variables sociodemográficas, gestacionales, relacionadas a la suplementación en el embarazo anterior y actual. Para el análisis de los factores asociados a la adherencia se usó el modelo GEE. En la segunda y tercera visita de seguimiento la adherencia incrementó en 4% y 8%, mientras que en la quinta y sexta, se redujo en 8% y 20,6%, respectivamente. Los factores que redujeron la adherencia fueron: falla en la dispensación (25, 3%), náuseas (9,5%), interacción de náuseas y vómitos (13,5%), y no le cae bien el suplemento (11%). En conclusión, la adherencia disminuye con el tiempo y los factores relacionados al suplemento y la falla en la distribución se relacionan a la reducción de esta
Anemia in pregnant women is a major public health problem worldwide. According to the registered prevalence, in Peru it persists as a moderate problem. Poor adherence to oral iron supplementation is one of the main barriers to the effectiveness of this intervention. The aim of this study was to determine the variation in adherence to oral iron supplements over time and the factors associated with it. To do this, the sentinel surveillance database of the "Study of Adherence to Iron Supplementation During Pregnancy in the Health Directions of Apurimac and Ayacucho", of general directorate of epidemiology (DGE), a longitudinal prospective cohort, was reanalyzed. A descriptive analysis of the 416 registered pregnant women and a bivariate and multivariate analysis based on 376 pregnant women was carried out. Sociodemographic, gestational, supplementation in the previous and current pregnancy variables were identified. For the analysis of the factors associated with adherence, the GEE model was used. At the second and third follow-up visit, adherence increased by 4% and 8%, while at the fifth and sixth, it decreased by 8% and 20,6%, respectively. The factors that reduced adherence were: dispensing failure (25,3%), nausea (9,5%), interaction of nausea and vomiting (13,5%), and did not like the supplement (11%). In conclusion, adherence decreases with time and the factors related to the supplement and the failure in the distribution are related to its reduction.
Tesis
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Oral iron"

1

Taehwa ŭi kipŏp: Iron kwa silche. Kyŏnggi-do Kwangmyŏng-si: Kyŏngjin, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Stobie, Shannon Blaire. The novel oral iron chelator, L1, in acute and chronic iron overload. Ottawa: National Library of Canada, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Olszewski, Jacek. Mikrostruktura oraz procesy przemagnesowania w magnetycznie twardych i miękkich stopach żelaza. Częstochowa: Wydawn. Politechniki Częstochowskiej, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Field archaeology: An introduction. 2nd ed. Abingdon, Oxon: Routledge, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

L'art du conteur dans les cafés traditionnels en Iran. Paris: Harmattan, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

1958-, Yi Chʻang-sik, ed. Kubi munhak iran muŏt inʾga. Sŏul-si: Pʻurŭn Sasangsa, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

S, Miller Marc. The irony of victory: WorldWar II and Lowell, Massachusetts. Urbana: University of Illinois Press, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ladjevardi, Habib. Reference guide to the Iranian oral history collection. 2nd ed. Cambridge, MA: Harvard University, Center for Middle Eastern Studies, Iranian Oral History Project, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bukowski, Zbigniew. Znaleziska bursztynu w zespołach z epoki brązu i z wczesnej epoki żelaza z dorzecza Odray oraz Wisły. Warszawa: Instytut Archeologii i Etnologii PAN, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kopyciński, Dariusz. Krystalizacja faz międzymetalicznych i cynku na żelazie oraz na jego nisko- i wysokowęglowych stopach podczas procesu cynkowania. Kraków: AGH Uczelniane Wydawnictwa Naukowo-Dydaktyczne, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Oral iron"

1

Moretti, Diego, and Nicole U. Stoffel. "Novel Approaches to Oral Iron Supplementation." In Nutrition and Health, 295–304. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-14521-6_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Crary, Shelley E., and George R. Buchanan. "Iron Deficiency: When and Why Oral Iron May Not Be Enough." In Controversies in Pediatric and Adolescent Hematology, 151–60. Basel: S. KARGER AG, 2013. http://dx.doi.org/10.1159/000350352.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Deters, A., and A. E. Kulozik. "Presumed iron deficiency anemia which fails to respond to oral iron." In Practical Algorithms in Pediatric Hematology and Oncology, 22–23. Basel: KARGER, 2003. http://dx.doi.org/10.1159/000069579.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

de Luna, Kathryn, Matthew Pawlowicz, and Jeffery Fleisher. "Lessons for Modern Environmental and Climate Policy from Iron Age South Central Africa." In Perspectives on Public Policy in Societal-Environmental Crises, 191–204. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-94137-6_13.

Full text
Abstract:
AbstractHow do we develop effective environmental and climate policy for regions of the world with few—if any—relevant paleoclimate, vegetation, and hydrological reconstructions and, therefore, impoverished models of the environmental and human impacts of future climate change? What if such regions are in countries with limited financial, institutional, or instrumental infrastructure to generate those records? Research in historical disciplines offer direct and indirect evidence of the relationships between societal change and past environmental and climate change, without resorting to bald instrumentalism, but, as this study shows, we need to broaden our historical toolkit if we are to develop such work in regions of the world where oral cultures and less monumental, less permanent material cultural traditions prevailed.
APA, Harvard, Vancouver, ISO, and other styles
5

Zimmermann, Michael, Pierre Adou, Toni Torresani, Christophe Zeder, and Richard Hurrell. "Persistence of Goiter Despite Oral Iodine Supplementation in Goitrous Chidren with Iron-Deficiency Anemia in the Côte ’Ivoire." In Trace Elements in Man and Animals 10, 587–90. New York, NY: Springer US, 2002. http://dx.doi.org/10.1007/0-306-47466-2_189.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Batoréo, Hanna J. "Chapter 5. On ironic puns in Portuguese authentic oral data." In Irony in Language Use and Communication, 109–26. Amsterdam: John Benjamins Publishing Company, 2017. http://dx.doi.org/10.1075/ftl.1.06bat.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Talarico, Valentina, Laura Giancotti, Giuseppe Antonio Mazza, Santina Marrazzo, Roberto Miniero, and Marco Bertini. "FERALGINE™ a New Oral iron Compound." In Iron Metabolism - Iron a Double‐Edged Sword [Working Title]. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.100445.

Full text
Abstract:
Management of iron deficiency (ID) and iron deficiency anemia (IDA) is primarily focused to remove, when possible, the underlying cause of ID; subsequently its treatment is primary focused on iron stores repletion. Ferrous sulphate (FS) remains the mainstay of treatment and it is recommended as the first-line treatment of ID and IDA in children as in adults by all guidelines of scientific societies. However the effectiveness of FS is largely compromised by increased adverse effects, poor compliance and discontinuation of treatment. A new oral iron source named FERALGINE™ (FBC-A) has been recently developed. This new molecule is a patented co-processed one-to-one ratio compound between Ferrous Bysglicinate Chelate (FBC) and Sodium Alginate (AA), obtained by using a spray drying technology. The data presented in this short review highlight the efficacy and safety of the treatment with FBC-A and support its use in adult patients with IDA. Furthermore the present review also provides preliminary evidence to suggest FBC-A as first-line treatment for ID/IDA in patients with celiac disease (CD) or inflammatory bowel diseases (IBD).
APA, Harvard, Vancouver, ISO, and other styles
8

Dahihandekar, Chinmayee, and Sweta Kale Pisulkar. "Abnormal Iron Metabolism and Its Effect on Dentistry." In Iron Metabolism - Iron a Double‐Edged Sword [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.104502.

Full text
Abstract:
Iron is a necessary micro-nutrient for proper functioning of the erythropoietic, oxidative and cellular metabolism. The iron balance in the body adversely affects the normal physiologic functioning of the body and structures in the oral cavity. Various abnormalities develop owing to improper iron metabolism in the body which reflects in the oral cavity. The toxicity of iron has to be well understood to immediately identify the hazardous effects which arise owing to it and to manage it. It has been very well mentioned in the chapter. The manifestations of defects of iron metabolism in the oral cavity should be carefully studied to improve the prognosis of the treatment of the same. Disorders related to iron metabolism should be managed for improvement in the quality of life of the patient.
APA, Harvard, Vancouver, ISO, and other styles
9

"The Iron Age archaeology of the southern Lake Malawi area." In Archaeology and Oral Tradition in Malawi, 89–110. Boydell & Brewer, 2020. http://dx.doi.org/10.2307/j.ctvxhrjp5.11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Atkinson, Martin E. "Radiological anatomy of the oral cavity." In Anatomy for Dental Students. Oxford University Press, 2013. http://dx.doi.org/10.1093/oso/9780199234462.003.0040.

Full text
Abstract:
The radiographs most frequently taken in general dental practice are of the teeth and their immidiate supporting tissues for detection of dental caries or assessment of bone loss in periodontal disease. Intraoral radiographs are taken by placing the X-ray-sensitive film or receptor in the mouth close to the teeth being investigated. Extraoral radiographs use larger films or receptors positioned externally and produce a view of the entire dentition and its supporting structures on a single film; they are used to ascertain the state of development of the dentitions prior to orthodontic treatment, for example. Dental panoramic tomographs (DPTs) are the most frequent extraoral radiographs. A radiograph is a negative photographic record. Dense structures such as bone are designated as radio-opaque; they absorb some X-rays and appear white on radiographs. More X-rays pass through less dense radiolucent structures such as air-filled cavities which show up as black areas. The contrast between different tissues of the structures which the X-ray beam passes through is determined by their radiodensity which, in turn, is largely due to their content of metallic elements. Calcium and iron are the prevalent heavy metals in the body. Calcium is combined with phosphate to form hydroxyapatite crystals in bones and mineralized tissues in teeth. Iron is present in haemoglobin in blood, but only large concentrations of blood, such as those found within the heart chambers, show up on X-rays. In sequence from densest to most lucent, the radiodensity of the dental and periodontal tissues are: enamel, dentine, cementum, compact bone, cancellous bone, demineralized carious enamel and dentine, dental soft tissues such as pulp and periodontal ligament, and air; gold and silver–mercury amalgam metallic restorative materials are even denser than enamel. A radiograph is a two-dimensional representation of a three-dimensional situation. The orientation of anatomical structures relative to the X-ray beam is a major factor determining their appearance on the film. For example, a beam travelling through the long axis of a radiodense structure will produce a whiter image on the film than one passing through its shorter axis because more X-rays are absorbed; the structure will also have a different shape.
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Oral iron"

1

Faria, Nuno, Dora Pereira, Bianca Mergler, and Jonathan Powell. "Ligand doping of iron oxide nanoparticles as an approach to novel oral iron therapeutics." In 2011 IEEE 11th International Conference on Nanotechnology (IEEE-NANO). IEEE, 2011. http://dx.doi.org/10.1109/nano.2011.6144520.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Spary-Kainz, Ulrike, Thomas Semlitsch, Sophie Rundel, Alexander Avian, Sereina Herzog, Heidelinde Jakse, and Andrea Siebenhofer. "102 Oral iron supplementation in pregnancy in austria: haphazard usage." In Preventing Overdiagnosis, Abstracts, August 2018, Copenhagen. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/bmjebm-2018-111070.102.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Al-hassi, Hafid Omar, Oliver Ng, Sian Faustini, Oliver Phipps, Edward Dickson, Manel Mangalika, Natalie Worton, Barrie Keeler, Austin Acheson, and Matthew Brookes. "OWE-26 Inflammatory responses in patients with colorectal cancer and iron deficiency anaemiatreated with oral iron." In British Society of Gastroenterology Annual Meeting, 17–20 June 2019, Abstracts. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2019. http://dx.doi.org/10.1136/gutjnl-2019-bsgabstracts.359.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Alas, Gema, Ronald E. Pagano, Jane Q. Nguyen, H. M. H. Nihal Bandara, Sergei A. Ivanov, Gennady A. Smolyakov, Dale L. Huber, Hugh D. C. Smyth, and Marek Osiński. "Effects of iron-oxide nanoparticles and magnetic fields on oral biofilms." In SPIE BiOS, edited by Marek Osiński, Wolfgang J. Parak, and Xing-Jie Liang. SPIE, 2017. http://dx.doi.org/10.1117/12.2256221.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ningrum, Fiki Cahya, Bhisma Murti, and Vitri Widyaningsih. "Relative Efficacy of Intravenous Iron Versus Oral Iron on Increasing Hemoglobin Level among Pregnant Women with Iron Deficiency Anemia: A Meta-Analysis." In The 6th International Conference on Public Health 2019. Masters Program in Public Health, Graduate School, Universitas Sebelas Maret, 2019. http://dx.doi.org/10.26911/the6thicph.03.18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Fernández González, M., M. Alonso Moreno, H. Rodríguez Ramallo, JL Pérez Blanco, P. Ciudad Gutierrez, ME Mingot Castellano, and R. Rubio Romero. "4CPS-252 Oral and intravenous iron in the treatment of perioperative anaemia." In 26th EAHP Congress, Hospital pharmacists – changing roles in a changing world, 23–25 March 2022. British Medical Journal Publishing Group, 2022. http://dx.doi.org/10.1136/ejhpharm-2022-eahp.235.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Altayeb, Yousra Bashir Fathalrhman, and Ecir Yılmaz. "Oral Squamous Cell Carcinoma (OSCC) Treatment by Magneti Nanoparticles (Hyperthermia Method): A Review." In 6th International Students Science Congress. Izmir International Guest Student Association, 2022. http://dx.doi.org/10.52460/issc.2022.020.

Full text
Abstract:
Squamous cell carcinoma (SCC) is the most commonly diagnosed oral cancer. It is a type of head and neck squamous cell carcinoma (HNSCC) oral cancer affects more than 300,000 people in a year. Oral cancer is the sixth most common malignant cancer. The traditional methods of treatment were used through surgery, followed by chemotherapy, but these methods are not effective enough for the treatment, so treatment was focused on using magnetic nanoparticles. Magnetic nanoparticles demolish only the cancer cells directly without affecting healthy cells. They can also be used to increase the effectiveness of the other treatment methods. Iron oxide nanoparticles, maghemite (Fe2O3) and magnetite (Fe3O4) are widely used in the diagnosis and treatment of cancerous diseases. Iron oxides NPs have distinctive properties as they have good biodegradability, very low toxicity, modifiability, and ease of preparation. the method of hyperthermia is one of the effective methods in the treatment of cancer. Because cancer cells show greater sensitivity to high temperature compared to normal cells.
APA, Harvard, Vancouver, ISO, and other styles
8

Li, Douglas, Fadi Asfour, Ryan Hunter, Carmen Reyes, and Dianne Newman. "The Effect Of Oral Iron Supplementation On Sputum Iron And Lung Function In Healthy And Acutely Ill Patients With Cystic Fibrosis." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a5270.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Katerina, KLIMOVA, Wayne Thomas, and Stephen Lewis. "PWE-049 Assessment of response and tolerance to oral iron supplements in patients with anaemia." In British Society of Gastroenterology Annual Meeting, 17–20 June 2019, Abstracts. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2019. http://dx.doi.org/10.1136/gutjnl-2019-bsgabstracts.373.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Phipps, Oliver, Mohammed N. Quraishi, Aditi Kumar, Edward A. Dickson, Oliver Ng, Austin G. Acheson, Andrew D. Beggs, Hafid O. Al-Hassi, and Matthew J. Brookes. "O54 Evaluating oral and intravenous iron therapy on bacterial populations in normal mucosa and colorectal tumour." In Abstracts of the BSG Campus, 21–29 January 2021. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2021. http://dx.doi.org/10.1136/gutjnl-2020-bsgcampus.54.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Oral iron"

1

Iron deficiency in people with chronic kidney disease can be managed with either oral or IV therapy. National Institute for Health Research, June 2019. http://dx.doi.org/10.3310/signal-000773.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Oral iron' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography